Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
In the herein reported case of a 42-year-old woman diagnosed with anxiety and depression, a long history of antidepressant ineffectiveness and adverse drug reactions was decisive for an in-depth medication review including pharmacogenetic panel testing. In detail, treatment attempts with paroxetine...
Main Authors: | Céline K. Stäuble, Markus L. Lampert, Thorsten Mikoteit, Martin Hatzinger, Kurt E. Hersberger, Henriette E. Meyer zu Schwabedissen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/7/673 |
Similar Items
-
Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying <i>CYP2D6</i>*4 Variants: A Case Report
by: Céline K. Stäuble, et al.
Published: (2021-06-01) -
Pharmacogenetics of antidepressants
by: Concetta eCrisafulli, et al.
Published: (2011-02-01) -
Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept
by: Céline K. Stäuble, et al.
Published: (2021-09-01) -
Pharmacogenetics of antidepressant drugs: An update
by: Crisafulli Concetta, et al.
Published: (2014-01-01) -
Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
by: L. K. Khokhlov, et al.
Published: (2019-05-01)